Article
Identification of Blood-based Non-invasive Biomarkers and Therapeutic Agents against Pancreatic Ductal Adenocarcinoma (PDAC): A Network-based Study
2020-01-10
Abstract excerpt
Pancreatic Ductal Adenocarcinoma (PDAC) is the most demolishing form of pancreatic cancer with poor prognosis and rising incidence. Difficulties in the early detection and aggressive biological nature of this disease are responsible for most of the therapeutic failures. In this study publicly available microarray expression data of full RNA from peripheral blood of PDAC patient has been utilized via network-based...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- df869a15-ae36-5219-8079-5729301594e6
- DOI
- 10.1101/2020.01.08.20016931
